サインイン 無料でサインアップします。

Last updated: 3 November 2022 at 9:09pm EST

Sunil Patel Net Worth




The estimated Net Worth of Sunil Patel is at least 13.8 百万$ dollars as of 2 November 2020. Mr. Patel owns over 1,000 units of Ligand Pharmaceuticals stock worth over 2,906,107$ and over the last 14 years he sold LGND stock worth over 10,550,079$. In addition, he makes 344,900$ as Independent Director at Ligand Pharmaceuticals.

Mr. Patel LGND stock SEC Form 4 insiders trading

Sunil has made over 8 trades of the Ligand Pharmaceuticals stock since 2011, according to the Form 4 filled with the SEC. Most recently he bought 1,000 units of LGND stock worth 82,520$ on 2 November 2020.

The largest trade he's ever made was selling 42,287 units of Ligand Pharmaceuticals stock on 16 August 2018 worth over 10,150,994$. On average, Sunil trades about 2,151 units every 116 days since 2010. As of 2 November 2020 he still owns at least 28,190 units of Ligand Pharmaceuticals stock.

You can see the complete history of Mr. Patel stock trades at the bottom of the page.





Sunil Patel biography

Sunil Patel serves as Independent Director of the Company. He has served as a member of Ligand’s board of directors since October 2010. He has more than 20 years of senior management and R&D experience in the biotechnology industry. Mr. Patel most recently was Executive Vice President and Chief Financial Officer for OncoMed Pharmaceuticals, a development-stage company focused on therapeutics targeting cancer stem cells. Mr. Patel has held senior management positions in corporate development, marketing, and strategy with BiPar Sciences, Allos Therapeutics, Connetics, Abgenix and Gilead Sciences. Mr. Patel also worked at McKinsey & Company serving biotech and pharmaceutical clients and has held scientific research positions at ZymoGenetics and ProCyte. Mr. Patel received his undergraduate degree in Chemistry at the University of California, Berkeley, and master’s degree in Molecular Bioengineering/Biotechnology at the University of Washington. In selecting Mr. Patel to serve as a director, the board considered, among other things, his valuable pharmaceutical and corporate development experience, including his service at OncoMed Pharmaceuticals. Ligand also benefits from Mr. Patel’s experience in serving as a senior member of management at both public and private biotechnology companies.

What is the salary of Sunil Patel?

As the Independent Director of Ligand Pharmaceuticals, the total compensation of Sunil Patel at Ligand Pharmaceuticals is 344,900$. There are 14 executives at Ligand Pharmaceuticals getting paid more, with John Higgins having the highest compensation of 6,770,380$.



How old is Sunil Patel?

Sunil Patel is 48, he's been the Independent Director of Ligand Pharmaceuticals since 2010. There are 12 older and 3 younger executives at Ligand Pharmaceuticals. The oldest executive at Ligand Pharmaceuticals, Inc. is John Lamattina, 70, who is the Independent Director.

What's Sunil Patel's mailing address?

Sunil's mailing address filed with the SEC is 3911 SORRENTO VALLEY BOULEVARD,, SUITE 110, SAN DIEGO, CA, 92121.

Insiders trading at Ligand Pharmaceuticals

Over the last 21 years, insiders at Ligand Pharmaceuticals have traded over 205,340,014$ worth of Ligand Pharmaceuticals stock and bought 2,116,600 units worth 27,601,439$ . The most active insiders traders include Partners L P/Ilbiotechnolog...、Partners L P/Ilbiotechnolog...、Partners L P/Ilbiotechnolog.... On average, Ligand Pharmaceuticals executives and independent directors trade stock every 22 days with the average trade being worth of 2,239,733$. The most recent stock trade was executed by Octavio Espinoza on 28 August 2024, trading 753 units of LGND stock currently worth 50,090$.



What does Ligand Pharmaceuticals do?

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.



What does Ligand Pharmaceuticals's logo look like?

Ligand Pharmaceuticals, Inc. logo

Complete history of Mr. Patel stock trades at Ligand Pharmaceuticals

日付
#
会社
 インサイダー
取引
取引
 株式 1株当たりの株価 合計金額 その後の株式数 ソース
2 Nov 2020 LGND Ligand Pharmaceuticals, Inc. Sunil Patel
購入する 1,000 82.52$ 82,520$
2 Nov 2020
28,190 ↗
2 Aug 2019 LGND Ligand Pharmaceuticals, Inc. Sunil Patel
購入する 1,000 95.98$ 95,980$
2 Aug 2019
26,359 ↗
16 Aug 2018 LGND Ligand Pharmaceuticals, Inc. Sunil Patel
販売 42,287 240.05$ 10,150,994$
16 Aug 2018
24,524 ↗
19 Mar 2015 LGND Ligand Pharmaceuticals, Inc. Sunil Patel
販売 4,591 74.42$ 341,662$
19 Mar 2015
37,100 ↗
23 May 2012 LGND Ligand Pharmaceuticals, Inc. Sunil Patel
購入する 1,500 11.38$ 17,070$
23 May 2012
29,705 ↗
10 Aug 2011 LGND Ligand Pharmaceuticals, Inc. Sunil Patel
購入する 5,000 10.74$ 53,700$
10 Aug 2011
25,705 ↗


Ligand Pharmaceuticals executives and stock owners

Ligand Pharmaceuticals executives and other stock owners filed with the SEC include: